Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul S Vedula

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Hematologic Malignancy Reports|October 25, 2017
Measurement of Residual Disease in Acute Myeloid LeukemiaRahul S Vedula, R Coleman Lindsley
Journal of General Internal Medicine|November 8, 2013
Complementary medicineRahul S Vedula, Gregory Britt, Richard I Kopelman, et al.
Leukemia & Lymphoma|April 1, 2026
Interstitial granulomatous drug reaction associated with tyrosine kinase inhibitor dasatinibGrant J Riew, Mihir K Patil, Soo Hyun Kim, et al.
Blood Advances|February 11, 2021
Somatic GATA2 mutations define a subgroup of myeloid malignancy patients at high risk for invasive fungal diseaseRahul S Vedula, Matthew P Cheng, Christine E Ronayne, et al.
Biosensors & Bioelectronics|February 24, 2011
Label-free multiplexed virus detection using spectral reflectance imagingCarlos A Lopez, George G Daaboul, Rahul S Vedula, et al.
American Journal of Hematology|April 10, 2021
Pretreatment clinical and genetic factors predict early post-treatment mortality in fit AML patients following inductionJ Erika Haydu, Yael Flamand, Rahul S Vedula, et al.
Open Forum Infectious Diseases|June 4, 2026
Invasive Fungal Sinusitis in Patients With Hematological Malignancies: A 20-Year Study From a Tertiary Academic US Hospital SystemTejas S Athni, Carolyn B Strauch, Victor Kovac, et al.
Blood|July 8, 2024
CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemiasRahul S Vedula, Hannah Q Karp, Jeremy Koob, et al.
Leukemia & Lymphoma|March 15, 2022
Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclaxEvan C Chen, Yiwen Liu, Courtney E Harris, et al.
Blood Advances|January 26, 2022
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapyJurjen Versluis, Manu Pandey, Yael Flamand, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Hematologic Malignancy Reports|October 25, 2017
Measurement of Residual Disease in Acute Myeloid LeukemiaRahul S Vedula, R Coleman Lindsley
Journal of General Internal Medicine|November 8, 2013
Complementary medicineRahul S Vedula, Gregory Britt, Richard I Kopelman, et al.
Leukemia & Lymphoma|April 1, 2026
Interstitial granulomatous drug reaction associated with tyrosine kinase inhibitor dasatinibGrant J Riew, Mihir K Patil, Soo Hyun Kim, et al.
Blood Advances|February 11, 2021
Somatic GATA2 mutations define a subgroup of myeloid malignancy patients at high risk for invasive fungal diseaseRahul S Vedula, Matthew P Cheng, Christine E Ronayne, et al.
Biosensors & Bioelectronics|February 24, 2011
Label-free multiplexed virus detection using spectral reflectance imagingCarlos A Lopez, George G Daaboul, Rahul S Vedula, et al.
American Journal of Hematology|April 10, 2021
Pretreatment clinical and genetic factors predict early post-treatment mortality in fit AML patients following inductionJ Erika Haydu, Yael Flamand, Rahul S Vedula, et al.
Open Forum Infectious Diseases|June 4, 2026
Invasive Fungal Sinusitis in Patients With Hematological Malignancies: A 20-Year Study From a Tertiary Academic US Hospital SystemTejas S Athni, Carolyn B Strauch, Victor Kovac, et al.
Blood|July 8, 2024
CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemiasRahul S Vedula, Hannah Q Karp, Jeremy Koob, et al.
Leukemia & Lymphoma|March 15, 2022
Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclaxEvan C Chen, Yiwen Liu, Courtney E Harris, et al.
Blood Advances|January 26, 2022
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapyJurjen Versluis, Manu Pandey, Yael Flamand, et al.
Pageof 2